Hopefully they can go for 3 more quarters without the need for a CR if they can gt a loan against the R&D grant of $900K. The sales team were put in place in September and from being in a sales role it usually takes 12 months before you really start to gain some momentum. It would be great so see some of the private health insurers start to rebate the product as that would defintely help with sales.
I cant help but feel that the US market will be slow moving in the beginning due to the need for a doctors prescription.
I would prefer to see the company put in place some distribution agreements where the distributor gets a cut so there is some owness on them to push the product through their own channels thus we are only paying for what they sell rather than incur all the costs upfront when cash needs to be preserved.
I hope they have some nice surprises next quarter but we will have to wait and see.
ALT Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held